Related Experiment Video

Updated: Apr 3, 2026

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
08:53

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

8.3K

Polyethylene Sebacate-Silymarin Nanoparticles with Enhanced Hepatoprotective Activity

Swati A Guhagarkar, Devang Shah, Mitesh D Patel

    Journal of Nanoscience and Nanotechnology
    |September 16, 2015
    PubMed

    More Related Videos

    Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces08:50

    Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces

    Published on: September 26, 2014

    10.7K
    Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo09:36

    Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

    Published on: February 5, 2019

    9.5K

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

    Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

    Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
    346